at the tricuspid and mitral sides were lower in AoC patients than in healthy group. The E/Ea ratio was significantly higher in patients than in control (6.2±2.1 vs 3.8±1, p<0.000). The LV (left ventricular) ejection fraction was not statistically different between AoC group and controls.
Results: 32 consecutive obese patients (age: 12,8 [8-17] years; z-score BMI: 5, 8 [2, [5] [6] [7] [8] 6 ]; 15 males; HOMA-IR: 2,1 [0, 7] ) were compared to 32 nonobese patients. There was no difference beween two groups for left ventricular ejection fraction and conventionnal diastolic mitral Doppler parameters. Obese subjects showed significantly larger left ventricular wall dimensions (End diastolic diameter: 45±5 vs 43±4 mm; p<0,05; left ventricular mass: 116±31 vs 79±18 g; p<0,005) and signs of early diastolic filling abnormalities on TDI (Ea: 18,1 vs 16,9 cm/s; p=0,02). LS and CS were significantly lower in obese group (LS: -18±2% vs -20±2%; p<0,05-CS: -18±3% vs -20,1±2 %; p<0,05) while RS did not differ. LS and CS were correlated with BMI (Respectively: r=0,5; p<0.05 and r=0,3; p<0.05). There was no correlation between strain parameters and body composition. There was no correlation between strain parameters and hs-CRP. LS was correlated with HOMA-IR (r: 0,45; p<0,05).
Conclusion:
Obesity in children is associated with significant impairment of longitudinal and circumferential myocardial strain. Conotruncal malformations are frequent and often associated with coronary artery anomalies. Coordinated development of the second heart field and cardiac neural crest cells is required to orchestrate outflow tract morphogenesis. Defects in one or other cell type results in a spectrum of conotruncal defects observed in human pathology and mouse models. TBX1, encoding a T-box transcription factor, is the major candidate gene for DiGeorge syndrome and is required for conotruncal development. Tbx1 -/-mouse embryos have a common arterial trunk and proximal coronary artery patterning defects. In the absence of Tbx1 there is a severe reduction in a subpopulation of second heart field cells contributing to subpulmonary myocardium. Sema3C, encoding a neurovascular guidance molecule, is expressed in a Tbx1-dependent domain in subpulmonary myocardium. Sema3C -/-embryos display common arterial trunk with interrupted aortic arch but coronary artery patterning appears normal. Here we present a comparative analysis of the evolution of common trunk in Tbx1 and Sema3C mouse models. These models of truncus display major anatomical differences visible at early stages in the width and the position of myocardial subdomains of the outflow tract and at fetal stages in truncal valve, coronary and great artery patterning. The Tbx1 null phenotype is similar to pulmonary atresia whereas in Sema3C -/ -hearts a hypoplastic aorta emerges from the common trunk leading to an interrupted aortic arch. We also investigated potential genetic interaction between Tbx1 and Sema3C, and identified a cryptic early role of Sema3C in pharyngeal arch artery formation revealed in Tbx1+/-embryos suggesting a potential modifier role of Sema3C in DiGeorge syndrome. In addition, we will present data from a microarray analysis of the midgestation mouse outflow tract that has identified additional genes expressed in subpulmonary myocardium, potentially contributing to conotruncal and coronary artery development. Background: The safety profile of propranolol in infantile hemangioma (IH) is generally good despite a risk of severe bradycardia. In infants, sinus bradycardia can be a sign of increased vagal tonus, involved in the etiopathogeny of the sudden infant death syndrome (SIDS), which occurs in the same age group as IH. In addition, infants with IH may combine several other risk factors for syncope or sudden death. Hence, we aimed to determine the frequency of sinus bradycardia in infants before propranolol initiation and cardiac outcome during treatment in children with baseline bradycardia.
Methods:
Retrospective observational study of infants treated with propranolol for IH from June 2008 to September 2010 at our institution. Prior to propranolol initiation, a detailed baseline cardiological assessment was systematically performed including cardiac ultrasonography and 24 hour-electrocardiographic heart rate monitoring. Further at-home long term monitoring was performed in the infants who had baseline episodes of bradycardia.
Results: Significant episodes of sinus bradycardia were found in 3 patients (12,5%), on baseline monitoring prior to propranolol initiation. Cardiorespiratory monitoring at home was thus implemented in these infants and maintained throughout treatment (duration 4 to 8 months). Tolerance was excellent in all three: no further episodes of sinusal bradycardia or other adverse events occurred.
Discussion: Although asymptomatic, baseline sinus bradycardia may not be uncommon in infants with hemangiomas. It does not seem to preclude the use of propranolol, as no severe sinusal bradycardia was noted on propranolol in our series.
